Metabolic enzymes moonlighting to drive enzalutamide resistance in prostate cancer

Maria Rusan, Simone Weiss, Karina Dalsgaard Sørensen*

*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperComment/debate/letter to the editorResearchpeer-review

Original languageEnglish
JournalTranslational andrology and urology
Volume13
Issue4
Pages (from-to)626-630
Number of pages5
ISSN2223-4683
DOIs
Publication statusPublished - Apr 2024

Keywords

  • clustered regularly interspaced short palindromic repeats screening (CRISPR screening)
  • enzalutamide resistance
  • metabolic enzymes
  • PGAM2
  • Prostate cancer

Cite this